PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt

Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 215; no. 12; pp. 3165 - 3179
Main Authors Uche, Uzodinma U, Piccirillo, Ann R, Kataoka, Shunsuke, Grebinoski, Stephanie J, D'Cruz, Louise M, Kane, Lawrence P
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 03.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation.
AbstractList Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of Listeria monocytogenes infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation.
This study demonstrates a role for the transmembrane regulator of PI3K (TrIP) in restricting early T cell activation, at least in part through effects on PI3K. It is also shown that levels of TrIP decrease preceding full T cell activation. Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of Listeria monocytogenes infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation.
Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation.
Author Kataoka, Shunsuke
Grebinoski, Stephanie J
D'Cruz, Louise M
Kane, Lawrence P
Uche, Uzodinma U
Piccirillo, Ann R
AuthorAffiliation 3 Asahi Kasei Pharma Corporation, Tokyo, Japan
4 Graduate Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
2 Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA
1 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
AuthorAffiliation_xml – name: 4 Graduate Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
– name: 1 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
– name: 2 Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA
– name: 3 Asahi Kasei Pharma Corporation, Tokyo, Japan
Author_xml – sequence: 1
  givenname: Uzodinma U
  orcidid: 0000-0002-9397-8117
  surname: Uche
  fullname: Uche, Uzodinma U
  organization: Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA
– sequence: 2
  givenname: Ann R
  surname: Piccirillo
  fullname: Piccirillo, Ann R
  organization: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
– sequence: 3
  givenname: Shunsuke
  surname: Kataoka
  fullname: Kataoka, Shunsuke
  organization: Asahi Kasei Pharma Corporation, Tokyo, Japan
– sequence: 4
  givenname: Stephanie J
  surname: Grebinoski
  fullname: Grebinoski, Stephanie J
  organization: Graduate Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
– sequence: 5
  givenname: Louise M
  orcidid: 0000-0003-0388-430X
  surname: D'Cruz
  fullname: D'Cruz, Louise M
  organization: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
– sequence: 6
  givenname: Lawrence P
  orcidid: 0000-0001-5198-516X
  surname: Kane
  fullname: Kane, Lawrence P
  email: lkane@pitt.edu
  organization: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA lkane@pitt.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30429249$$D View this record in MEDLINE/PubMed
BookMark eNpVkDtPwzAUhS1URB-wMaOMDKT1K4m9IFUVj6iVyFBmy3GcxiWNi51W4t-Tqg_BcHWHc3TuPd8Q9BrbaADuERwjyOhkrTdjDFHSDbsCAxRRGPKIsB4YQIhxiCBM-mDo_RpCRGkU34A-gRRzTPkAzLN0TtIMTZYuzQKnfeuMan0gVWv2sjW2CWwZLAOl69oHbeXsblUFpqlMbs5qlpL5ZPrV3oLrUtZe3532CHy-vixn7-Hi4y2dTRehIoy2Ics1U1zyQnLKk-7zHKtSlzxHJYwLxcoCskgzRjQsNClUzLQmPGZ5UTClSkJG4PmYu93lG10o3bRO1mLrzEa6H2GlEf-VxlRiZfcixgmnMO4CHk8Bzn7vus5iY_yhoWy03XmBESEM04jyzvp0tCpnvXe6vJxBUBz4i46_OPPv7A9_X7uYz8DJLzo5g2Y
CitedBy_id crossref_primary_10_1007_s00280_022_04493_5
crossref_primary_10_26508_lsa_202201683
crossref_primary_10_3390_ani10101924
crossref_primary_10_1016_j_ejphar_2024_176753
crossref_primary_10_3390_ijms20235841
crossref_primary_10_1126_sciimmunol_abm0631
crossref_primary_10_1158_1078_0432_CCR_18_4134
crossref_primary_10_1016_j_omtm_2021_09_019
crossref_primary_10_1126_sciadv_abo4250
crossref_primary_10_3390_cells11142162
crossref_primary_10_1126_science_abo2296
crossref_primary_10_1111_all_15819
crossref_primary_10_33396_1728_0869_2021_10_21_28
crossref_primary_10_12688_f1000research_26928_1
crossref_primary_10_3390_ijms22094969
crossref_primary_10_3390_cancers13235912
crossref_primary_10_1038_s41422_020_0301_1
crossref_primary_10_3389_fonc_2022_1042196
crossref_primary_10_4049_jimmunol_2000584
crossref_primary_10_1016_j_jbior_2020_100722
crossref_primary_10_1038_s41598_022_15230_6
crossref_primary_10_1084_jem_20202084
crossref_primary_10_3390_pathogens11080822
crossref_primary_10_1016_j_ccell_2021_02_007
crossref_primary_10_1158_2326_6066_CIR_22_0702
crossref_primary_10_1038_s41598_020_66224_1
crossref_primary_10_1016_j_phymed_2024_155608
Cites_doi 10.1021/bi100687f
10.1038/nri3198
10.1111/j.1600-065X.1986.tb01501.x
10.4049/jimmunol.149.7.2255
10.1146/annurev.biochem.67.1.481
10.1038/nri3278
10.1096/fasebj.12.15.1731
10.1038/onc.2008.247
10.1002/eji.201141653
10.1016/0014-5793(84)80473-1
10.1038/nrc2664
10.1016/j.bbrc.2007.04.096
10.1042/BST0350177
10.1038/sj.emboj.7601520
10.1073/pnas.1005183107
10.1073/pnas.0800928105
10.3389/fimmu.2012.00245
10.18632/oncotarget.260
10.1042/bst0310270
10.1128/JVI.00006-15
10.1016/j.ctrv.2003.07.007
10.4049/jimmunol.173.11.6806
10.1084/jem.20171820
10.1016/S1074-7613(03)00081-5
10.1158/0008-5472.CAN-08-0025
10.4049/jimmunol.1402554
10.1159/000147844
10.1038/nri1461
10.1038/ng.2846
10.1038/nature04606
10.1111/imr.12148
10.3389/fimmu.2012.00151
10.1016/j.immuni.2011.01.012
10.1021/bi00005a003
10.1016/0092-8674(91)90314-O
10.1016/j.mib.2003.12.002
10.1074/jbc.M109.041715
10.1126/science.296.5573.1655
10.2174/1568011023353705
10.4049/jimmunol.0903170
10.2174/1389450114666140106100909
10.4049/jimmunol.172.9.5441
10.1146/annurev-immunol-032712-095946
ContentType Journal Article
Copyright 2018 Uche et al.
2018 Uche et al. 2018
Copyright_xml – notice: 2018 Uche et al.
– notice: 2018 Uche et al. 2018
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1084/jem.20172018
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate TrIP regulates T cell activation
EISSN 1540-9538
EndPage 3179
ExternalDocumentID 10_1084_jem_20172018
30429249
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R21 AI126845
– fundername: NIAID NIH HHS
  grantid: R01 AI103022
– fundername: NIAID NIH HHS
  grantid: R21 AI095730
– fundername: NIH HHS
  grantid: S10 OD011925
– fundername: ;
– fundername: PHS
  grantid: S10OD011925
– fundername: Public Health Service
  grantid: AI126845; AI095730
– fundername: PHS
  grantid: AI103022
GroupedDBID ---
-~X
18M
29K
2WC
36B
4.4
53G
5GY
5RE
5VS
ABOCM
ABZEH
ACGFO
ACNCT
ACPRK
ADBBV
AENEX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C45
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
EMB
F5P
F9R
FRP
GX1
H13
HYE
IH2
K-O
KQ8
L7B
N9A
NPM
O5R
O5S
OK1
P2P
P6G
R.V
RHF
RHI
RPM
SJN
TR2
TRP
UHB
W8F
WOQ
AAYXX
CITATION
7X8
AFNDN
5PM
ID FETCH-LOGICAL-c384t-8be8c9a9da9497017b2cfef9b1f06dc8fd085e883e0de3dc68ee3968bdd8ccf33
IEDL.DBID RPM
ISSN 0022-1007
IngestDate Tue Sep 17 21:11:35 EDT 2024
Wed Jul 17 03:55:38 EDT 2024
Thu Sep 26 16:08:07 EDT 2024
Sat Sep 28 08:17:27 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License 2018 Uche et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c384t-8be8c9a9da9497017b2cfef9b1f06dc8fd085e883e0de3dc68ee3968bdd8ccf33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-5198-516X
0000-0002-9397-8117
0000-0003-0388-430X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279406/
PMID 30429249
PQID 2133824549
PQPubID 23479
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6279406
proquest_miscellaneous_2133824549
crossref_primary_10_1084_jem_20172018
pubmed_primary_30429249
PublicationCentury 2000
PublicationDate 20181203
PublicationDateYYYYMMDD 2018-12-03
PublicationDate_xml – month: 12
  year: 2018
  text: 20181203
  day: 3
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of experimental medicine
PublicationTitleAlternate J Exp Med
PublicationYear 2018
Publisher Rockefeller University Press
Publisher_xml – name: Rockefeller University Press
References Hedrick (2023072603554513500_bib21) 2012; 12
Kane (2023072603554513500_bib25) 2004; 172
Engelman (2023072603554513500_bib13) 2009; 9
Cerdan (2023072603554513500_bib7) 1992; 149
Li (2023072603554513500_bib28) 2007; 26
Okkenhaug (2023072603554513500_bib35) 2003; 31
Agoulnik (2023072603554513500_bib1) 2011; 2
Pamer (2023072603554513500_bib36) 2004; 4
Han (2023072603554513500_bib17) 2012; 3
Antignano (2023072603554513500_bib2) 2010; 184
Patthy (2023072603554513500_bib37) 1984; 171
Zhu (2023072603554513500_bib45) 2007; 358
He (2023072603554513500_bib20) 2008; 68
Wong (2023072603554513500_bib44) 2014; 46
Sauer (2023072603554513500_bib38) 2008; 105
Fresno Vara (2023072603554513500_bib14) 2004; 30
Cantley (2023072603554513500_bib3) 2002; 296
Mikels (2023072603554513500_bib31) 2009; 284
Castellino (2023072603554513500_bib6) 1997; 212
Fruman (2023072603554513500_bib16) 1998; 67
Shiow (2023072603554513500_bib39) 2006; 440
Chi (2023072603554513500_bib8) 2012; 12
Théry (2023072603554513500_bib41) 1996; 156
Wong (2023072603554513500_bib43) 2003; 18
Tolbert (2023072603554513500_bib42) 2010; 107
Fruman (2023072603554513500_bib15) 2007; 35
Carracedo (2023072603554513500_bib5) 2008; 27
Macintyre (2023072603554513500_bib29) 2011; 34
DeFrances (2023072603554513500_bib11) 2012; 42
Christen (2023072603554513500_bib9) 2010; 49
Cao (2023072603554513500_bib4) 2002; 2
Clayton (2023072603554513500_bib10) 2015; 89
Newton (2023072603554513500_bib32) 2012; 3
Okkenhaug (2023072603554513500_bib34) 2010; 346
Hawse (2023072603554513500_bib19) 2015; 194
Huynh (2023072603554513500_bib22) 2014; 258
Menhart (2023072603554513500_bib30) 1995; 34
Singh (2023072603554513500_bib40) 2018; 215
Dillon (2023072603554513500_bib12) 2014; 15
Okkenhaug (2023072603554513500_bib33) 2013; 31
Lara-Tejero (2023072603554513500_bib26) 2004; 7
Irving (2023072603554513500_bib23) 1991; 64
Ji (2023072603554513500_bib24) 1998; 12
Haughton (2023072603554513500_bib18) 1986; 93
Li (2023072603554513500_bib27) 2004; 173
References_xml – volume: 49
  start-page: 7131
  year: 2010
  ident: 2023072603554513500_bib9
  article-title: Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape
  publication-title: Biochemistry.
  doi: 10.1021/bi100687f
  contributor:
    fullname: Christen
– volume: 12
  start-page: 325
  year: 2012
  ident: 2023072603554513500_bib8
  article-title: Regulation and function of mTOR signalling in T cell fate decisions
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3198
  contributor:
    fullname: Chi
– volume: 93
  start-page: 35
  year: 1986
  ident: 2023072603554513500_bib18
  article-title: The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.1986.tb01501.x
  contributor:
    fullname: Haughton
– volume: 212
  start-page: 46
  year: 1997
  ident: 2023072603554513500_bib6
  article-title: The kringle domains of human plasminogen
  publication-title: Ciba Found. Symp.
  contributor:
    fullname: Castellino
– volume: 149
  start-page: 2255
  year: 1992
  ident: 2023072603554513500_bib7
  article-title: Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.149.7.2255
  contributor:
    fullname: Cerdan
– volume: 67
  start-page: 481
  year: 1998
  ident: 2023072603554513500_bib16
  article-title: Phosphoinositide kinases
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.biochem.67.1.481
  contributor:
    fullname: Fruman
– volume: 12
  start-page: 649
  year: 2012
  ident: 2023072603554513500_bib21
  article-title: FOXO transcription factors throughout T cell biology
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3278
  contributor:
    fullname: Hedrick
– volume: 12
  start-page: 1731
  year: 1998
  ident: 2023072603554513500_bib24
  article-title: Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis
  publication-title: FASEB J.
  doi: 10.1096/fasebj.12.15.1731
  contributor:
    fullname: Ji
– volume: 27
  start-page: 5527
  year: 2008
  ident: 2023072603554513500_bib5
  article-title: The PTEN-PI3K pathway: of feedbacks and cross-talks
  publication-title: Oncogene.
  doi: 10.1038/onc.2008.247
  contributor:
    fullname: Carracedo
– volume: 42
  start-page: 2754
  year: 2012
  ident: 2023072603554513500_bib11
  article-title: Inhibition of T-cell activation by PIK3IP1
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201141653
  contributor:
    fullname: DeFrances
– volume: 171
  start-page: 131
  year: 1984
  ident: 2023072603554513500_bib37
  article-title: Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases
  publication-title: FEBS Lett.
  doi: 10.1016/0014-5793(84)80473-1
  contributor:
    fullname: Patthy
– volume: 9
  start-page: 550
  year: 2009
  ident: 2023072603554513500_bib13
  article-title: Targeting PI3K signalling in cancer: opportunities, challenges and limitations
  publication-title: Nat. Rev. Cancer.
  doi: 10.1038/nrc2664
  contributor:
    fullname: Engelman
– volume: 346
  start-page: 57
  year: 2010
  ident: 2023072603554513500_bib34
  article-title: PI3Ks in lymphocyte signaling and development
  publication-title: Curr. Top. Microbiol. Immunol.
  contributor:
    fullname: Okkenhaug
– volume: 358
  start-page: 66
  year: 2007
  ident: 2023072603554513500_bib45
  article-title: PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2007.04.096
  contributor:
    fullname: Zhu
– volume: 35
  start-page: 177
  year: 2007
  ident: 2023072603554513500_bib15
  article-title: The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST0350177
  contributor:
    fullname: Fruman
– volume: 26
  start-page: 494
  year: 2007
  ident: 2023072603554513500_bib28
  article-title: Metalloproteases regulate T-cell proliferation and effector function via LAG-3
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7601520
  contributor:
    fullname: Li
– volume: 107
  start-page: 13264
  year: 2010
  ident: 2023072603554513500_bib42
  article-title: Structural basis for agonism and antagonism of hepatocyte growth factor
  publication-title: Proc. Natl. Acad. Sci. USA.
  doi: 10.1073/pnas.1005183107
  contributor:
    fullname: Tolbert
– volume: 105
  start-page: 7797
  year: 2008
  ident: 2023072603554513500_bib38
  article-title: T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
  publication-title: Proc. Natl. Acad. Sci. USA.
  doi: 10.1073/pnas.0800928105
  contributor:
    fullname: Sauer
– volume: 3
  start-page: 245
  year: 2012
  ident: 2023072603554513500_bib17
  article-title: The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2012.00245
  contributor:
    fullname: Han
– volume: 2
  start-page: 321
  year: 2011
  ident: 2023072603554513500_bib1
  article-title: INPP4B: the new kid on the PI3K block
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.260
  contributor:
    fullname: Agoulnik
– volume: 31
  start-page: 270
  year: 2003
  ident: 2023072603554513500_bib35
  article-title: PI3K-signalling in B- and T-cells: insights from gene-targeted mice
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/bst0310270
  contributor:
    fullname: Okkenhaug
– volume: 89
  start-page: 3723
  year: 2015
  ident: 2023072603554513500_bib10
  article-title: Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression
  publication-title: J. Virol.
  doi: 10.1128/JVI.00006-15
  contributor:
    fullname: Clayton
– volume: 30
  start-page: 193
  year: 2004
  ident: 2023072603554513500_bib14
  article-title: PI3K/Akt signalling pathway and cancer
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/j.ctrv.2003.07.007
  contributor:
    fullname: Fresno Vara
– volume: 173
  start-page: 6806
  year: 2004
  ident: 2023072603554513500_bib27
  article-title: Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.173.11.6806
  contributor:
    fullname: Li
– volume: 215
  start-page: 2429
  year: 2018
  ident: 2023072603554513500_bib40
  article-title: B cell adaptor for PI3-kinase (BCAP) modulates CD8+ effector and memory T cell differentiation
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20171820
  contributor:
    fullname: Singh
– volume: 18
  start-page: 499
  year: 2003
  ident: 2023072603554513500_bib43
  article-title: Feedback regulation of pathogen-specific T cell priming
  publication-title: Immunity.
  doi: 10.1016/S1074-7613(03)00081-5
  contributor:
    fullname: Wong
– volume: 68
  start-page: 5591
  year: 2008
  ident: 2023072603554513500_bib20
  article-title: PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-0025
  contributor:
    fullname: He
– volume: 194
  start-page: 4615
  year: 2015
  ident: 2023072603554513500_bib19
  article-title: Cutting Edge: Differential Regulation of PTEN by TCR, Akt, and FoxO1 Controls CD4+ T Cell Fate Decisions
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1402554
  contributor:
    fullname: Hawse
– volume: 156
  start-page: 162
  year: 1996
  ident: 2023072603554513500_bib41
  article-title: Roles of kringle domain-containing serine proteases in epithelial-mesenchymal transitions during embryonic development
  publication-title: Acta Anat. (Basel).
  doi: 10.1159/000147844
  contributor:
    fullname: Théry
– volume: 4
  start-page: 812
  year: 2004
  ident: 2023072603554513500_bib36
  article-title: Immune responses to Listeria monocytogenes
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri1461
  contributor:
    fullname: Pamer
– volume: 46
  start-page: 33
  year: 2014
  ident: 2023072603554513500_bib44
  article-title: Inactivating CUX1 mutations promote tumorigenesis
  publication-title: Nat. Genet.
  doi: 10.1038/ng.2846
  contributor:
    fullname: Wong
– volume: 440
  start-page: 540
  year: 2006
  ident: 2023072603554513500_bib39
  article-title: CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs
  publication-title: Nature.
  doi: 10.1038/nature04606
  contributor:
    fullname: Shiow
– volume: 258
  start-page: 117
  year: 2014
  ident: 2023072603554513500_bib22
  article-title: Signals and pathways controlling regulatory T cells
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.12148
  contributor:
    fullname: Huynh
– volume: 3
  start-page: 151
  year: 2012
  ident: 2023072603554513500_bib32
  article-title: Regulation of T cell homeostasis and responses by pten
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2012.00151
  contributor:
    fullname: Newton
– volume: 34
  start-page: 224
  year: 2011
  ident: 2023072603554513500_bib29
  article-title: Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2011.01.012
  contributor:
    fullname: Macintyre
– volume: 34
  start-page: 1482
  year: 1995
  ident: 2023072603554513500_bib30
  article-title: Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation
  publication-title: Biochemistry.
  doi: 10.1021/bi00005a003
  contributor:
    fullname: Menhart
– volume: 64
  start-page: 891
  year: 1991
  ident: 2023072603554513500_bib23
  article-title: The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways
  publication-title: Cell.
  doi: 10.1016/0092-8674(91)90314-O
  contributor:
    fullname: Irving
– volume: 7
  start-page: 45
  year: 2004
  ident: 2023072603554513500_bib26
  article-title: T cell responses to Listeria monocytogenes
  publication-title: Curr. Opin. Microbiol.
  doi: 10.1016/j.mib.2003.12.002
  contributor:
    fullname: Lara-Tejero
– volume: 284
  start-page: 30167
  year: 2009
  ident: 2023072603554513500_bib31
  article-title: Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.041715
  contributor:
    fullname: Mikels
– volume: 296
  start-page: 1655
  year: 2002
  ident: 2023072603554513500_bib3
  article-title: The phosphoinositide 3-kinase pathway
  publication-title: Science.
  doi: 10.1126/science.296.5573.1655
  contributor:
    fullname: Cantley
– volume: 2
  start-page: 667
  year: 2002
  ident: 2023072603554513500_bib4
  article-title: Kringle structures and antiangiogenesis
  publication-title: Curr. Med. Chem. Anticancer Agents.
  doi: 10.2174/1568011023353705
  contributor:
    fullname: Cao
– volume: 184
  start-page: 2805
  year: 2010
  ident: 2023072603554513500_bib2
  article-title: SHIP is required for dendritic cell maturation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0903170
  contributor:
    fullname: Antignano
– volume: 15
  start-page: 65
  year: 2014
  ident: 2023072603554513500_bib12
  article-title: Therapeutic targeting of cancers with loss of PTEN function
  publication-title: Curr. Drug Targets.
  doi: 10.2174/1389450114666140106100909
  contributor:
    fullname: Dillon
– volume: 172
  start-page: 5441
  year: 2004
  ident: 2023072603554513500_bib25
  article-title: A proline-rich motif in the C terminus of Akt contributes to its localization in the immunological synapse
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.9.5441
  contributor:
    fullname: Kane
– volume: 31
  start-page: 675
  year: 2013
  ident: 2023072603554513500_bib33
  article-title: Signaling by the phosphoinositide 3-kinase family in immune cells
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-032712-095946
  contributor:
    fullname: Okkenhaug
SSID ssj0014456
Score 2.4599752
Snippet Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease...
This study demonstrates a role for the transmembrane regulator of PI3K (TrIP) in restricting early T cell activation, at least in part through effects on PI3K....
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 3165
SubjectTerms Animals
Carrier Proteins - genetics
Carrier Proteins - immunology
Class Ia Phosphatidylinositol 3-Kinase - genetics
Class Ia Phosphatidylinositol 3-Kinase - immunology
HEK293 Cells
Humans
Intracellular Signaling Peptides and Proteins
Listeria monocytogenes - immunology
Listeriosis - genetics
Listeriosis - immunology
Listeriosis - pathology
Lymphocyte Activation
Membrane Proteins
Mice
Mice, Transgenic
T-Lymphocytes - immunology
T-Lymphocytes - pathology
Title PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt
URI https://www.ncbi.nlm.nih.gov/pubmed/30429249
https://search.proquest.com/docview/2133824549
https://pubmed.ncbi.nlm.nih.gov/PMC6279406
Volume 215
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT4QwEJ7oHowX41t8bGqiR-TRAuW4MW7EzRoOa-KN0HYa8cEaF_-_LQvG1ZvnAmm_TpjXNzMAF1SIkoVauCVX6LKAa5dT5bspJtKIR6S4tAH96X18-8DuHqPHNYj6WpiWtC9FdVW_vl3V1VPLrXx_k17PE_Py6XUcGinyY28d1hNKexe9Sx0w1o5sbWnqlgLQsd19zrxntLXnRmX7gZ3TZz15636sqqQ_duZvuuQP_TPehq3OcCSj5QZ3YA3rXdiYdqnxPZjk2YRmeeDNPrKc2Ikb5g_XLIgtXFiGXclckxmxkfoF6cbzkKp-qkTVr-YZnXijl2YfHsY3s-tbt5uU4ErKWeNygVymZarKlKWJOaEIpUadikD7sZJcK2NZIecUfYVUyZgj0jTmQpm7kJrSAxjU8xqPgKDgZckSrRMmGdOhSMJIREpHKXKMdODAZQ9W8b5siFG0iWzOCoNv0ePrwHmPZGEk1h6urHH-uShC6xaHzDimDhwukf3-Un8lDiQrmH8_YLthr64YIWm7YndCcfzvN09g02685arQUxg0H594ZiyORgyNrZ1Nhq2cfQH9adeV
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkGgv5dHSbgutkdpjNg87iXNECLRhWZTDUnGLYnssUkoWsdlLf33tJEYsPbVnJ1Em3zgz4_lmBuAbFaJikRZexRV6LOTa41QFXoapNOoRKy7tgf7sKplcs4ub-GYDYlcL05H2pajHza_7cVPfdtzKh3vpO56YX8xOk8hoUZD4r2DL7NcodUH6kDxgrBva2hHVLQlg4LsHnPk_0VafG6MdhHZSn43lbQCybpT-8jRfEiafWaDzHfjh3r0nntyNV60Yy98v2jr-s3C78HbwSclJv7wHG9jsw_ZsyLq_g2mRT2lehP78MS-IHeZhfp7tktiaiP5Elyw0mRObBFiSYfIPqZvbWtRutcjp1D-5a9_D9fnZ_HTiDUMYPEk5az0ukMusylSVsSw1n05EUqPORKiDREmulXHakHOKgUKqZMIRaZZwoQzMUlN6AJvNosGPQFDwqmKp1imTjOlIpFEsYqXjDDnGOhzBd4dC-dD32ii7HDlnpQGudMCN4NhBVJrNYIWrGlyslmVkI-6ImZh3BB96yJ6e5LAeQboG5tMFttH2-oqBqGu4PUDy6b_v_AqvJ_PZZXmZX00_wxsrREeJoYew2T6u8Mg4Nq340qnxHx3P-JY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkFAvFPqA7QNcqT1m87CT2EcEXRG2i3JYJNRLFNtjkVKyKzZ76a-vnQdi6Y2zHSuTb5yZ8XyeAfhGpSxZZKRXco0eC7nxONWBJzBVVj1izZU70J9dJRfX7PImvnnS6qsl7StZjes_9-O6um25lct75Q88MT-fnSWR1aIg8Zfa-K9gx-7ZSAyBep9AYKxt3NqS1R0RoOe8B5z5v9HdQLeGOwhdtz4Xz7sgZNMw_edtPidNPrFCkzfwa3j_jnxyN143cqz-Pivt-CIB92Gv903JaTflALawfgu7sz77_g6meTalWR7684csJ66ph_2JNivi7kZ0J7tkYcicuGTAivQdgEhV31ayGkbzjE7907vmPVxPfszPLry-GYOnKGeNxyVyJUqhS8FEaj-fjJRBI2RogkQrbrR13pBzioFGqlXCEalIuNQWbmUo_QDb9aLGIyAoeVmy1JiUKcZMJNMolrE2sUCOsQlH8H1Aolh2NTeKNlfOWWHBKwbwRvB1gKmwm8IJV9a4WK-KyEXeEbOx7wgOO9geVxrwHkG6AejjBFdwe3PEwtQW3u5h-fjiJ09gNz-fFD-zq-kneO1kaJkx9DNsNw9r_GL9m0Yet5r8D_GC-xY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PIK3IP1%2FTrIP+restricts+activation+of+T+cells+through+inhibition+of+PI3K%2FAkt&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Uche%2C+Uzodinma+U&rft.au=Piccirillo%2C+Ann+R&rft.au=Kataoka%2C+Shunsuke&rft.au=Grebinoski%2C+Stephanie+J&rft.date=2018-12-03&rft.eissn=1540-9538&rft.volume=215&rft.issue=12&rft.spage=3165&rft_id=info:doi/10.1084%2Fjem.20172018&rft_id=info%3Apmid%2F30429249&rft.externalDocID=30429249
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon